Literature DB >> 29998215

It is time to accelerate building local vaccine adjuvant manufacturing capacity.

Christopher B Fox1.   

Abstract

Keywords:  developing country vaccine manufacturers; malaria vaccine; pandemic influenza vaccine; technology transfer; vaccine adjuvant

Year:  2017        PMID： 29998215      PMCID： PMC5933535          DOI： 10.1177/2051013617733259

Source DB:  PubMed          Journal:  Ther Adv Vaccines Immunother        ISSN： 2515-1355


× No keyword cloud information.
  9 in total

1.  Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant.

Authors:  Crina Stavaru; Adrian Onu; Emilia Lupulescu; Catalin Tucureanu; Orhan Rasid; Ene Vlase; Cristin Coman; Iuliana Caras; Alina Ghiorghisor; Laurentiu Berbecila; Vlad Tofan; Richard A Bowen; Nicole Marlenee; Airn Hartwig; Helle Bielefeldt-Ohmann; Susan L Baldwin; Neal Van Hoeven; Thomas S Vedvick; Chuong Huynh; Michael K O'Hara; Diana L Noah; Christopher B Fox
Journal:  Hum Vaccin Immunother       Date:  2015-11-30       Impact factor: 3.452

Review 2.  Key roles of adjuvants in modern vaccines.

Authors:  Steven G Reed; Mark T Orr; Christopher B Fox
Journal:  Nat Med       Date:  2013-12-05       Impact factor: 53.440

3.  Are we entering a new age for human vaccine adjuvants?

Authors:  Derek T O'Hagan; Christopher B Fox
Journal:  Expert Rev Vaccines       Date:  2015-05-06       Impact factor: 5.217

4.  Intellectual property, technology transfer and manufacture of low-cost HPV vaccines in India.

Authors:  Swathi Padmanabhan; Tahir Amin; Bhaven Sampat; Robert Cook-Deegan; Subhashini Chandrasekharan
Journal:  Nat Biotechnol       Date:  2010-07       Impact factor: 54.908

5.  Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania.

Authors:  Christopher B Fox; Chuong Huynh; Michael K O'Hara; Adrian Onu
Journal:  Vaccine       Date:  2012-10-25       Impact factor: 3.641

6.  Technology transfer of an oil-in-water vaccine-adjuvant for strengthening pandemic influenza preparedness in Indonesia.

Authors:  Roland Ventura; Livia Brunner; Bambang Heriyanto; Otto de Boer; Michael O'Hara; Chuong Huynh; Mahendra Suhardono; Nicolas Collin
Journal:  Vaccine       Date:  2012-08-08       Impact factor: 3.641

Review 7.  Challenges and Opportunities While Developing a Group A Meningococcal Conjugate Vaccine Within a Product Development Partnership: A Manufacturer's Perspective From the Serum Institute of India.

Authors:  Prasad S Kulkarni; Muriel Socquet; Suresh S Jadhav; Subhash V Kapre; F Marc LaForce; Cyrus S Poonawalla
Journal:  Clin Infect Dis       Date:  2015-11-15       Impact factor: 9.079

8.  Challenges and successes for the grantees and the Technical Advisory Group of WHO's influenza vaccine technology transfer initiative.

Authors:  Gary Grohmann; Donald P Francis; Jaspal Sokhey; James Robertson
Journal:  Vaccine       Date:  2016-08-06       Impact factor: 3.641

9.  Considerations for sustainable influenza vaccine production in developing countries.

Authors:  Claudia Nannei; Christopher Chadwick; Hiba Fatima; Shoshanna Goldin; Myriam Grubo; Alexandra Ganim
Journal:  Vaccine       Date:  2016-09-07       Impact factor: 3.641
  9 in total
  2 in total

Review 1.  Better Pandemic Influenza Preparedness through Adjuvant Technology Transfer: Challenges and Lessons Learned.

Authors:  Céline H Lemoine; Reviany V Nidom; Roland Ventura; Setyarina Indrasari; Irine Normalina; Kuncoro Puguh Santoso; Francis Derouet; Christophe Barnier-Quer; Gerrit Borchard; Nicolas Collin; Chairul A Nidom
Journal:  Vaccines (Basel)       Date:  2021-05-05

2.  Squalene Emulsion Manufacturing Process Scale-Up for Enhanced Global Pandemic Response.

Authors:  Tony Phan; Christian Devine; Erik D Laursen; Adrian Simpson; Aaron Kahn; Amit P Khandhar; Steven Mesite; Brad Besse; Ken J Mabery; Elizabeth I Flanagan; Christopher B Fox
Journal:  Pharmaceuticals (Basel)       Date:  2020-07-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.